Company overview
Basic information
Company name
4rais, UAB
Company code
302536188
VAT code
LT100005603013
Registered address
Šiauliai, Aerouosto g. 7-403, LT-77103
Registration date
2010-08-11
Company age: 16 y. 2 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Website
https://www.brodvejauspica.lt
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Restaurant activities
Ownership form
Private without foreign capital
UAB "4rais"
Company code: 302536188
Address: Šiauliai, Aerouosto g. 7-403, LT-77103
VAT code: LT100005603013
Description
This description was generated by artificial intelligence.
4rais, UAB (company code 302536188) is an operational private limited liability company registered in 2010. The company is privately owned, with Lithuanian natural and legal persons holding more than 50% of the authorised capital and no foreign investor capital. Its governance is described as CEO only, and it is classified as a small company operating in the sector of national private non-financial companies. The company’s main activity is under EVRK code I.56.11.00, Restaurant activities. It is based in Šiauliai, Aerouosto g. 7-403, LT-77103, in Šiauliu m. municipality, Šiauliu county. Financially, 2025 was the latest financial year reported: revenue reached €571.1K, up 7.2% year on year, and net profit increased to €5.3K, with a profit margin of 0.9%. Revenue growth over two years was 8.6%. At the end of 2025, equity stood at €3.3K, liabilities at €40.4K, and total assets at €43.6K. Staff data show 18 average employees so far in 2026, compared with 17 in 2025, and the average monthly wage so far in 2026 was €1,232.87, up 6.5% year on year. Estimated annual payroll is €266.3K.
Download a detailed company report
Make confident decisions with all the information about 4rais, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.